Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab Bronchoscopy Study in Uncontrolled Asthma
NCT02099656Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of lebrikizumab in asthma, sponsored by Roche. Started Nov 2014; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02099656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099656.